Cargando…
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
BACKGROUND: Within one year after its emergence, more than 108 million people acquired SARS-CoV-2 and almost 2·4 million succumbed to COVID-19. New SARS-CoV-2 variants of concern (VoC) are emerging all over the world, with the threat of being more readily transmitted, being more virulent, or escapin...
Autores principales: | Abdelnabi, Rana, Boudewijns, Robbert, Foo, Caroline S., Seldeslachts, Laura, Sanchez-Felipe, Lorena, Zhang, Xin, Delang, Leen, Maes, Piet, Kaptein, Suzanne J.F., Weynand, Birgit, Vande Velde, Greetje, Neyts, Johan, Dallmeier, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143995/ https://www.ncbi.nlm.nih.gov/pubmed/34049240 http://dx.doi.org/10.1016/j.ebiom.2021.103403 |
Ejemplares similares
-
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022) -
Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022) -
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022) -
Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
por: Abdelnabi, Rana, et al.
Publicado: (2021) -
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
por: Abdelnabi, Rana, et al.
Publicado: (2022)